<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H6580BE07F2214AD6B3313391E7400075" public-private="public">
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>110 HR 7299 IH: To direct the Secretary of Defense and the Secretary of
</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2008-11-20</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
	<form>
		<distribution-code display="yes">I</distribution-code>
		<congress>110th CONGRESS</congress>
		<session>2d Session</session>
		<legis-num>H. R. 7299</legis-num>
		<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action>
			<action-date date="20081120">November 20, 2008</action-date>
			<action-desc><sponsor name-id="C000116">Mr. Cannon</sponsor> (for
			 himself and <cosponsor name-id="N000179">Mrs. Napolitano</cosponsor>)
			 introduced the following bill; which was referred to the
			 <committee-name committee-id="HAS00">Committee on Armed
			 Services</committee-name>, and in addition to the Committee on
			 <committee-name committee-id="HVR00">Veterans’ Affairs</committee-name>, for a
			 period to be subsequently determined by the Speaker, in each case for
			 consideration of such provisions as fall within the jurisdiction of the
			 committee concerned</action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To direct the Secretary of Defense and the Secretary of
		  Veterans Affairs to make payments for certain treatments of traumatic brain
		  injury and post-traumatic stress disorder.</official-title>
	</form>
	<legis-body id="H67A919B70FAC44069BD71EAA4693DCE4" style="OLC">
		<section id="H5E1D381982614020A03EB9AA31A2D589" section-type="section-one"><enum>1.</enum><header>payment for treatment of
			 members of the Armed Forces and veterans for traumatic brain injury and
			 post-traumatic stress disorder</header>
			<subsection id="H494B2BA6ACCB4AFFB784E600C55539D"><enum>(a)</enum><header>Payment
			 process</header><text display-inline="yes-display-inline">The Secretary of
			 Defense and the Secretary of Veterans Affairs shall each establish a process
			 through which each Secretary shall provide payment for treatments (including
			 diagnostic testing) of traumatic brain injury and post-traumatic stress
			 disorder received by members of the Armed Forces and veterans in health care
			 facilities other than military treatment facilities or Department of Veterans
			 Affairs medical facilities. Such process shall provide that payment be made
			 directly to the health care facility furnishing the treatment.</text>
			</subsection><subsection id="H65677CDB5BA3439E9DD17FDFF361D824"><enum>(b)</enum><header>Conditions for
			 payment</header><text display-inline="yes-display-inline">The approval by a
			 Secretary for payment for a treatment pursuant to subsection (a) shall be
			 subject to the following conditions:</text>
				<paragraph id="HDEF09C6080FA43B39646E12FDBAD16A6"><enum>(1)</enum><text display-inline="yes-display-inline">Any drug or device used in the treatment
			 must be approved by the Food and Drug Administration for any purpose.</text>
				</paragraph><paragraph id="H5EA99BED557546E2BD303663008C2140"><enum>(2)</enum><text>A
			 treatment protocol must be approved for the treatment by an institutional
			 review board operating in accordance with regulations issued by the Secretary
			 of Health and Human Services.</text>
				</paragraph><paragraph id="H434616299504488AA002F84C5BD6000"><enum>(3)</enum><text display-inline="yes-display-inline">The approved treatment protocol (including
			 any patient disclosure requirements) must be used by the health care provider
			 delivering the treatment.</text>
				</paragraph><paragraph id="HC60805F0003140E8B2CE200508762F00"><enum>(4)</enum><text display-inline="yes-display-inline">The patient receiving the treatment must
			 demonstrate an improvement on one or more of the following:</text>
					<subparagraph id="H5EBD9DB008E8498DAB5E83B27D713096"><enum>(A)</enum><text>Standardized
			 independent pre-treatment and post-treatment neuropsychological testing.</text>
					</subparagraph><subparagraph id="H55E305BC94B6476890553EB2CE4C9385"><enum>(B)</enum><text>Accepted survey
			 instruments.</text>
					</subparagraph><subparagraph id="H3542AA683B924E248250B681A28556C7"><enum>(C)</enum><text>Neurological
			 imaging.</text>
					</subparagraph><subparagraph id="HBFE4BB7E3D874C49A208BA8E1362882F"><enum>(D)</enum><text>Clinical
			 examination.</text>
					</subparagraph></paragraph></subsection><subsection id="H637221537899472600D708BAC293D735"><enum>(c)</enum><header>Payment
			 deadline</header><text display-inline="yes-display-inline">The Secretary of
			 Defense and the Secretary of Veterans Affairs shall make a payment for a
			 treatment pursuant to subsection (a) not later than 30 days after a member of
			 the Armed Forces or veteran (or health care provider on behalf of such member
			 or veteran) submits to the Secretary documentation regarding the treatment. The
			 Secretary of Defense and the Secretary of Veterans Affairs shall ensure that
			 the documentation required under this subsection may not be an undue burden on
			 the member of the Armed Forces or veteran.</text>
			</subsection><subsection commented="no" id="H030596427E2A41198373B056A0B9CA29"><enum>(d)</enum><header>Data collection
			 and availability</header>
				<paragraph commented="no" id="H141DCB07A44640F4BEA242ECD442C440"><enum>(1)</enum><header>In
			 General</header><text display-inline="yes-display-inline">The Secretary of
			 Defense and the Secretary of Veterans Affairs shall jointly develop and
			 maintain a database containing data from each patient case involving the use of
			 a treatment under this Act. The Secretaries shall ensure that the database
			 preserves confidentiality and be made available only—</text>
					<subparagraph id="H11637B9A536748F9911C65F5AD59308"><enum>(A)</enum><text>for third-party
			 payer examination;</text>
					</subparagraph><subparagraph id="H649AD19027484DCC90C23E1971EBE606"><enum>(B)</enum><text>to the appropriate
			 congressional committees and employees of the Department of Defense, the
			 Department of Veterans Affairs, and appropriate State agencies; and</text>
					</subparagraph><subparagraph id="H0A32CAE532EF453AA7C6B5257F8DBF00"><enum>(C)</enum><text display-inline="yes-display-inline">concerning the data of a patient case
			 involving the use of a treatment under this Act, to the primary investigator of
			 the institutional review board that approved such treatment.</text>
					</subparagraph></paragraph><paragraph commented="no" id="H851C0B0CE54E455F8F44B4A52553B197"><enum>(2)</enum><header>Enrollment in
			 Institutional Review Board Study</header><text>In the case of a patient
			 enrolled in a registered institutional review board study, results may be
			 publically distributable in accordance with regulations and practices as of the
			 date of the enactment of this Act.</text>
				</paragraph></subsection></section></legis-body>
</bill>


